science

Paediatric-use marketing authorisation

Paediatric-use marketing authorisation is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Paediatric-use marketing authorisation rather than just read about it. In short: Paediatric-use marketing authorisations (PUMA) are granted by the European Medicines Agency (EMA) for medical products that are intended exclusively for paediatric use, that is, for use in patients younger than 18 years. Like ordinary EMA marketing authorisations, a PUMA approval is valid in all countries of the European Economic Area (the European Union as well as Iceland, Liechtenstein, and Norway).

Key takeaways

Paediatric-use marketing authorisation belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Paediatric-use marketing authorisation to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Paediatric-use marketing authorisation from memory before moving on to harder problems.

Reference excerpt

Paediatric-use marketing authorisations (PUMA) are granted by the European Medicines Agency (EMA) for medical products that are intended exclusively for paediatric use, that is, for use in patients younger than 18 years. Like ordinary EMA marketing authorisations, a PUMA approval is valid in all countries of the European Economic Area (the European Union as well as Iceland, Liechtenstein, and Norway). The PUMA process was established to make it more profitable for pharmaceutical companies to market drugs for children. For this purpose, new data used for PUMA approved drugs are protected for 10 years, and the applications are partially exempt from fees. In September 2011, the first drug was approved under this process. It was Buccolam, a buccal application form of midazolam for the treatment of seizures.

References

Worked examples

Example 1 — a first encounter with Paediatric-use marketing authorisation

Start with the simplest possible case. Write down what Paediatric-use marketing authorisation claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Paediatric-use marketing authorisation before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Paediatric-use marketing authorisation ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Paediatric-use marketing authorisation

In research: Paediatric-use marketing authorisation appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Paediatric-use marketing authorisation in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Paediatric-use marketing authorisation is common in secondary-school and first-year university syllabi. It links to neighbouring topics Health and the European Union, Pharmacology stubs, so understanding it makes those chapters shorter.
In everyday life: Look for Paediatric-use marketing authorisation outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Paediatric-use marketing authorisation” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Paediatric-use marketing authorisation in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Paediatric-use marketing authorisation means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Paediatric-use marketing authorisation out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Paediatric-use marketing authorisation in simple terms?

Why does Paediatric-use marketing authorisation matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Paediatric-use marketing authorisation?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Paediatric-use marketing authorisation.